![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » European Commission Invites Feedback on Pediatric, Rare Disease Laws
European Commission Invites Feedback on Pediatric, Rare Disease Laws
October 30, 2018
The European Commission is seeking feedback on EU legislation relating to medicines for children and rare diseases.
The commission particularly wants stakeholder input on whether the legislation adequately promotes the development, research and marketing of such products. It also wants to assess the strengths and weaknesses of the legislation and get a better sense of how incentives have historically been applied.
The commission is soliciting feedback until Jan. 4.
Upcoming Events
-
21Oct